Rapid Development of Achalasia After SARS-CoV-2 Infection: PCR Analysis of Esophageal Muscle Tissue

Salih Samo,Falak Hamo,Ameer Hamza,Rena Yadlapati,Peter J. Kahrilas,Ann Wozniak PhDAnn Wozniak
DOI: https://doi.org/10.14309/ajg.0000000000002669
2024-01-25
The American Journal of Gastroenterology
Abstract:Introduction: Achalasia has been linked to viruses. We have observed cases of rapid-developing achalasia post-COVID-19. Methods: We aimed to prospectively evaluate esophageal muscle for SARS-CoV-2 from patients with rapid-onset achalasia post-COVID-19 and compare them to achalasia predating COVID-19 and achalasia with no COVID-19. Results: Compared to long-standing achalasia predating COVID-19 and long-standing achalasia with no COVID-19, the achalasia post- COVID-19 subjects had significantly higher levels of mRNA for the SARS-CoV-2 nucleocapsid (N) protein, which correlated with a significant increase in the inflammatory markers NLRP3 and TNF. Discussion: SARS-CoV-2, the virus responsible for COVID-19, is a possible trigger for achalasia.
gastroenterology & hepatology
What problem does this paper attempt to address?